Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Evolus Inc's Business Segments
Evolus Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2026
Reportable Segments
1
Largest Segment
Reportable
Total Revenue
$ 73
Regions Reported
-
Revenue Share by Reportable Segment - Q1 FY2026
- Reportable0%
Revenue by Reportable Segment - Q1 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Reportable | $ 73 | - |
Revenue by Product & Service Category - Q1 FY2026
- Product99.8%
- Jeuveau90.6%
- Evolysse9.2%
- Service0.5%
Revenue by Product & Service Category - Q1 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 73 | 99.8% |
| Jeuveau | $ 66 | 90.6% |
| Evolysse | $ 7 | 9.2% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
1 more categories available
Sign in to unlock the full Evolus Inc dataset.
Description of Evolus Inc
Evolus Inc is a biotechnology and aesthetics company that is headquartered in Newport Beach, California. The company specializes in the development and commercialization of medical products that improve the appearance and well-being of individuals. Evolus Inc was founded in 2012 by a team of healthcare professionals and biotech industry veterans who had a vision of transforming the aesthetic industry through innovation.
One of Evolus Inc's flagship products is Jeuveau, a prescription medicine that is used to improve the appearance of frown lines between the eyebrows in adults. Jeuveau is a botulinum toxin type A injectable that works by blocking the nerve signals that cause muscles to contract. The treatment temporarily relaxes the muscles, thereby smoothing out the wrinkles and lines on the face. Jeuveau was approved by the US Food and Drug Administration (FDA) in 2019 and is the first new botulinum toxin approved for aesthetics in over a decade.
Evolus Inc is also actively engaged in the research and development of new medical products for aesthetics and other therapeutic areas. The company has a robust pipeline of programs in various stages of development, including biosimilars, topical formulations, and neurotoxins. Evolus Inc has a strong focus on using advanced technologies to improve the safety, efficacy, and convenience of its products.
In addition to its core operations, Evolus Inc is committed to advancing the aesthetics industry through education and collaboration. The company partners with healthcare providers and industry experts to advance best practices and promote patient safety. It also supports research initiatives that seek to better understand the science behind aging and aesthetics.
Evolus Inc is led by a team of seasoned executives with extensive experience in the biotech and aesthetics industries. The company is publicly traded on the NASDAQ stock exchange and has a global reach through its partnerships with distributors and healthcare providers. Evolus Inc has earned recognition for its innovative products, commitment to quality, and dedication to improving patient outcomes.
One of Evolus Inc's flagship products is Jeuveau, a prescription medicine that is used to improve the appearance of frown lines between the eyebrows in adults. Jeuveau is a botulinum toxin type A injectable that works by blocking the nerve signals that cause muscles to contract. The treatment temporarily relaxes the muscles, thereby smoothing out the wrinkles and lines on the face. Jeuveau was approved by the US Food and Drug Administration (FDA) in 2019 and is the first new botulinum toxin approved for aesthetics in over a decade.
Evolus Inc is also actively engaged in the research and development of new medical products for aesthetics and other therapeutic areas. The company has a robust pipeline of programs in various stages of development, including biosimilars, topical formulations, and neurotoxins. Evolus Inc has a strong focus on using advanced technologies to improve the safety, efficacy, and convenience of its products.
In addition to its core operations, Evolus Inc is committed to advancing the aesthetics industry through education and collaboration. The company partners with healthcare providers and industry experts to advance best practices and promote patient safety. It also supports research initiatives that seek to better understand the science behind aging and aesthetics.
Evolus Inc is led by a team of seasoned executives with extensive experience in the biotech and aesthetics industries. The company is publicly traded on the NASDAQ stock exchange and has a global reach through its partnerships with distributors and healthcare providers. Evolus Inc has earned recognition for its innovative products, commitment to quality, and dedication to improving patient outcomes.
Evolus Inc is a prominent entity in the cosmetic and aesthetic industry, characterized by its focus on innovative products and services designed to address the evolving demands of consumers seeking aesthetic solutions, particularly alternatives to Botox. The company operates primarily within two segments: Aesthetic Dermatology Products and Aesthetic Dermatology Services.
1) Aesthetic Dermatology Products
Evolus’s product line encompasses a variety of advanced solutions aimed at enhancing beauty and addressing age-related concerns. This segment is primarily driven by:
a) Jeuveau (PrabotulinumtoxinA-xvfs)
- Overview: Jeuveau stands as Evoluss flagship product and the first FDA-approved neuromodulator that serves as an alternative to Botox. It is specifically designed for the aesthetic market and focuses on the treatment of glabellar lines (the frown lines between the eyebrows).
- Mechanism: Jeuveau works by temporarily relaxing the muscles that contribute to the formation of these lines, resulting in a smoother, more youthful appearance.
- Administration and Duration: Jeuveau is typically administered through injections and has a duration of effect similar to Botox, generally lasting three to six months, depending on the individuals response to the treatment.
b) DWP-450
- Stage of Development: DWP-450 is currently in pre-clinical development. The product is aimed at expanding the company’s portfolio of aesthetic treatments by addressing additional cosmetic indications beyond wrinkle treatment.
- Potential Applications: Although specific treatment applications have not yet been disclosed, the products development suggests a focus on broader aesthetic concerns that could complement the existing offerings.
2) Aesthetic Dermatology Services
In addition to its products, Evolus also provides a range of aesthetic dermatology services through its Evolus Experience Centers. These centers are strategically located in major metropolitan areas across the United States and offer a variety of treatments, enhancing the overall customer experience and providing personalized care. Key services include:
a) Jeuveau Treatments
- Service Description: This service involves the administration of Jeuveau to patients wishing to diminish the appearance of frown lines and create a smoother facial profile.
- Treatment Experience: The sessions are typically quick, often completed within a 15 to 30-minute appointment, allowing for convenience and comfort for patients.
b) Dermal Filler Treatments
- Product Range: Evolus offers an array of hyaluronic acid-based fillers, including Revanesse and Revanesse Versa.
- Treatment Indications: These fillers are utilized to restore volume, enhance facial contours, and reduce the appearance of wrinkles and fine lines, catering to various aesthetic needs.
- Technique: Treatments are tailored to the individual’s specific concerns, ensuring a natural and balanced result.
c) CoolSculpting
- Procedure Overview: This innovative non-invasive procedure targets localized fat deposits through cryolipolysis, where fat cells are frozen and subsequently eliminated by the body over time.
- Applications: CoolSculpting is ideal for patients looking for body contouring solutions without the need for surgical intervention, making it an attractive option for many.
d) Laser Treatments
- Service Variety: The Evolus centers offer a diverse range of laser treatments, including:
- Laser Hair Removal: Aimed at long-term reduction of unwanted hair.
- Skin Resurfacing: Designed to improve skin texture, tone, and overall appearance by targeting surface imperfections.
- Skin Rejuvenation: Focused on revitalizing the skin through various laser modalities, helping to treat sun damage, pigmentation, and other age-related concerns.
Conclusion
In conclusion, Evolus Inc. presents a comprehensive portfolio of aesthetic dermatology products and services that cater to a broad spectrum of cosmetic desires—from temporary wrinkle reduction to long-term body sculpting solutions. The companys commitment to quality and innovation, alongside its strong focus on patient care through the Evolus Experience Centers, positions it as a significant player within the growing aesthetic market, addressing the needs of those seeking effective and advanced cosmetic enhancements.
1) Aesthetic Dermatology Products
Evolus’s product line encompasses a variety of advanced solutions aimed at enhancing beauty and addressing age-related concerns. This segment is primarily driven by:
a) Jeuveau (PrabotulinumtoxinA-xvfs)
- Overview: Jeuveau stands as Evoluss flagship product and the first FDA-approved neuromodulator that serves as an alternative to Botox. It is specifically designed for the aesthetic market and focuses on the treatment of glabellar lines (the frown lines between the eyebrows).
- Mechanism: Jeuveau works by temporarily relaxing the muscles that contribute to the formation of these lines, resulting in a smoother, more youthful appearance.
- Administration and Duration: Jeuveau is typically administered through injections and has a duration of effect similar to Botox, generally lasting three to six months, depending on the individuals response to the treatment.
b) DWP-450
- Stage of Development: DWP-450 is currently in pre-clinical development. The product is aimed at expanding the company’s portfolio of aesthetic treatments by addressing additional cosmetic indications beyond wrinkle treatment.
- Potential Applications: Although specific treatment applications have not yet been disclosed, the products development suggests a focus on broader aesthetic concerns that could complement the existing offerings.
2) Aesthetic Dermatology Services
In addition to its products, Evolus also provides a range of aesthetic dermatology services through its Evolus Experience Centers. These centers are strategically located in major metropolitan areas across the United States and offer a variety of treatments, enhancing the overall customer experience and providing personalized care. Key services include:
a) Jeuveau Treatments
- Service Description: This service involves the administration of Jeuveau to patients wishing to diminish the appearance of frown lines and create a smoother facial profile.
- Treatment Experience: The sessions are typically quick, often completed within a 15 to 30-minute appointment, allowing for convenience and comfort for patients.
b) Dermal Filler Treatments
- Product Range: Evolus offers an array of hyaluronic acid-based fillers, including Revanesse and Revanesse Versa.
- Treatment Indications: These fillers are utilized to restore volume, enhance facial contours, and reduce the appearance of wrinkles and fine lines, catering to various aesthetic needs.
- Technique: Treatments are tailored to the individual’s specific concerns, ensuring a natural and balanced result.
c) CoolSculpting
- Procedure Overview: This innovative non-invasive procedure targets localized fat deposits through cryolipolysis, where fat cells are frozen and subsequently eliminated by the body over time.
- Applications: CoolSculpting is ideal for patients looking for body contouring solutions without the need for surgical intervention, making it an attractive option for many.
d) Laser Treatments
- Service Variety: The Evolus centers offer a diverse range of laser treatments, including:
- Laser Hair Removal: Aimed at long-term reduction of unwanted hair.
- Skin Resurfacing: Designed to improve skin texture, tone, and overall appearance by targeting surface imperfections.
- Skin Rejuvenation: Focused on revitalizing the skin through various laser modalities, helping to treat sun damage, pigmentation, and other age-related concerns.
Conclusion
In conclusion, Evolus Inc. presents a comprehensive portfolio of aesthetic dermatology products and services that cater to a broad spectrum of cosmetic desires—from temporary wrinkle reduction to long-term body sculpting solutions. The companys commitment to quality and innovation, alongside its strong focus on patient care through the Evolus Experience Centers, positions it as a significant player within the growing aesthetic market, addressing the needs of those seeking effective and advanced cosmetic enhancements.